Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Benedicto Parker"'
Autor:
Ran Yang, Bronwen Foreman, Malathi Perugula, Jean-Pierre Lindenmayer, Anzalee Khan, Abraham Goldring, Benedicto Parker, Owen Jones, Joanne Yoon, Amanda Hefner, Javeria Sahib, Sophia Borne, Gulshan Begum, Isidora Ljuri, Amod Thanju
BACKGROUND: A patient’s readiness for discharge can be assessed from the perspectives of the clinician, patient, and family. Criterion-based assessment by the clinician is the most commonly reported method, but there is no ecologically valid method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96bcc4edac69e13e5f46e0fa8597d27d
https://europepmc.org/articles/PMC6455667/
https://europepmc.org/articles/PMC6455667/
Autor:
Amod Thanju, Mohan Parak, Anzalee Khan, Amanda Hefner, Matthew J. Hoptman, Mila Kirstie-Kulsa, Joanne Yoon, Benedicto Parker, Anthony O. Ahmed, Owen Jones, Jean-Pierre Lindenmayer, Marc Budgazad, Harinder Gill, Abraham Goldring, Isidora Ljuri
BACKGROUND: The association between schizophrenia and violence is an important issue in psychiatry. The impact of several factors (social cognition, neurocognition, alexithymia, emotion regulation capacity, and the therapeutic milieu) on aggression i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72bfbebbf08396417e262e50471fc114
https://europepmc.org/articles/PMC6455827/
https://europepmc.org/articles/PMC6455827/
Autor:
Amandeep Kaur, Anzalee Khan, Ran Yang, Benedicto Parker, Isidora Ljuri, Mila Kirstie C. Kulsa, Tania Sultana, Jean-Pierre Lindenmayer
Publikováno v:
Brain Stimulation, Vol 12, Iss 1, Pp 54-61 (2019)
Background Transcranial direct-current stimulation (tDCS), a non-invasive neurostimulation treatment, has been reported in a number of sham-controlled studies to show significant improvements in treatment-resistant auditory hallucinations in schizoph
Autor:
Anzalee Khan, Susan R. McGurk, Amod Thanju, Veronica Ozog, Abraham Goldring, Kiara Buccellato, Isidora Ljuri, Mohan Parak, Samantha Fregenti, Gianna Capodilupo, Benedicto Parker, Jean-Pierre Lindenmayer, Mila Kirstie C. Kulsa
Publikováno v:
Schizophrenia research. 201
Objectives Cognitive remediation therapy (CRT) has shown significant improvement in cognition in schizophrenia. However, effect sizes of CRT have been reported to be modest raising the issue how to augment the effects of CRT on neurocognition and soc
Autor:
Benedicto Parker, Amod Thanju, Mohan Parak, Abraham Goldring, Jean-Pierre Lindenmayer, Bronwen Foreman, Anzalee Khan, Owen Jones, Alexandra Romano, Amanda Hefner
Publikováno v:
Schizophrenia Bulletin. 45:S218-S219
BACKGROUND: Few studies have compared clinical evaluations of negative symptoms to those done by patients. Self-report tools may better reflect the patients’ subjective experience. The Self-Evaluation of Negative Symptoms (SNS; Dollfus et al., 2015
Autor:
Jean-Pierre Lindenmayer, Tania Sultana, Amandeep Kaur, Benedicto Parker, Anzalee Khan, Isidora Ljuri, Mila Kirstie-Kulsa, Rang Yang
Publikováno v:
Schizophrenia Bulletin
Background Transcranial direct-current stimulation (tDCS), a noninvasive neurostimulation treatment, has been reported to show improvements in treatment-resistant auditory hallucinations in patients with schizophrenia. tDCS administered over a limite
Autor:
Jean-Pierre Lindenmayer, Anzalee Khan, Amandeep Kaur, Isidora Ljuri, Tania Sultana, Kristie Kulsa, Benedicto Parker, Ran Yang
Publikováno v:
Biological Psychiatry. 83:S440
Autor:
Anzalee Khan, Benedicto Parker, Isidora Ljuri, Amod Thanju, Serge Sevy, Susan R. McGurk, Abraham Goldring, Jean-Pierre Lindenmayer, Mohan Parak
Publikováno v:
Biological Psychiatry. 83:S318
Publikováno v:
The Journal of Clinical Psychiatry. 68:368-379
OBJECTIVE Primary negative symptoms are intrinsic to the pathology of schizophrenia and are associated with significant deficits in motivation, verbal and nonverbal communication, affect, and cognitive and social functioning. Overall, atypical antips
Autor:
Pál Czobor, Miranda Chakos, Leslie Citrome, Adel Iskander, Jean-Pierre Lindenmayer, Benedicto Parker, Jeffrey A. Lieberman, J. A. N. Volavka, Brian Sheitman
Publikováno v:
Journal of Clinical Psychopharmacology. 21:448-453
The role of olanzapine in treatment-resistant schizophrenia is still unresolved. This article presents an open-label, prospective, 14-week trial with olanzapine in patients with schizophrenia and schizoaffective disorder selected for unambiguous resi